These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22173196)

  • 1. Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient.
    Barberán J; Mensa J; Llamas JC; Ramos IJ; Ruiz JC; Marín JR; Tello PB; Massana MB; Vidal JB; Viñas JM; Huelva FJ; Pons EC; Mediavilla JD; Morfa ML; Barrigón FE; Avellán PF; López SG; García CG; Maraver DH; Guía AL; Jiménez JL; Chacón EM; Rubio MO; Oteyza JP; Ramírez GR; Contreras RR; Barbero AR; Tarrats MR; Félix DR; Godoy PS; Salinas AS; Alonso MA; Torroba Jde L; Ferreiras DV; López LV; García JM; Perea JR; Moreno RC; Cáncer RC; Abete JF; Rodríguez JG; Gómez JG; Pedrosa EG; Baranda JM; García FJ; Camps IR; Lleti MS; Cisneros Jde L;
    Rev Esp Quimioter; 2011 Dec; 24(4):263-70. PubMed ID: 22173196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Invasive fungal infection in haematology patients].
    Vallejo Llamas JC; Ruiz-Camps I
    Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):572-9. PubMed ID: 23079614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of invasive fungal infections in high-risk haematological patients: what have we learnt in the past 10 years?
    Vallejo C; Vázquez L; Cabrera Martín JR; Carreras E; García Rodríguez J; Ruiz Camps I; Fortún J; Mensa J; Barberán J
    Rev Esp Quimioter; 2013 Dec; 26(4):378-86. PubMed ID: 24399355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated guidelines for managing fungal diseases in hematology patients.
    Hicheri Y; Toma A; Maury S; Pautas C; Mallek-Kaci H; Cordonnier C
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1049-60. PubMed ID: 20818948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnosis and the invasive fungal infection in patients with hematological diseases].
    Shen JZ; Fu HY
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):401-2. PubMed ID: 16008841
    [No Abstract]   [Full Text] [Related]  

  • 7. Uncommon yeast infections in hematological patients: from diagnosis to treatment.
    Caira M; Trecarichi EM; Tumbarello M; Leone G; Pagano L
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1067-75. PubMed ID: 22029524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical antifungal treatment: a valid alternative for invasive fungal infection.
    Vallejo C; Barberán J
    Rev Esp Quimioter; 2011 Sep; 24(3):117-22. PubMed ID: 21947092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy.
    Cornely OA; Aversa F; Cook P; Jones B; Michallet M; Shea T; Vallejo C
    Eur J Haematol; 2011 Oct; 87(4):289-301. PubMed ID: 21752098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances and challenges in the treatment of invasive fungal infections.
    Shao PL; Huang LM; Hsueh PR
    Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis and treatment of invasive fungal infection in neutropenic patients].
    Vallejo C; Rovira M
    Rev Esp Quimioter; 2010 Dec; 23(4):177-83. PubMed ID: 21191555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
    Karthaus M; Hentrich M
    Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of amphotericin B in the treatment of invasive fungal infection in 111 hematological disorder patients with neutrocytopenia].
    Tong HY; Zhang FJ; Xiao F; Qian WB; Meng HT; Mai WY; Tong Y; Mao LP; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):472-5. PubMed ID: 19035181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal therapy in invasive fungal infections.
    Chen SC; Playford EG; Sorrell TC
    Curr Opin Pharmacol; 2010 Oct; 10(5):522-30. PubMed ID: 20598943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of fungal infections in the immunocompromised host.
    Mahfouz T; Anaissie E
    Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical importance of azoles in antifungal therapy: treatment or prophylaxis with new azoles in hematology].
    Vazquez Lopez L
    Rev Esp Quimioter; 2004 Mar; 17(1):98-100. PubMed ID: 15201932
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical manifestation and treatment of blood disease combined with invasive fungal infection].
    Shen ZX; Chen QS
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1447-8. PubMed ID: 16061018
    [No Abstract]   [Full Text] [Related]  

  • 19. [Up-date on the treatment of serious fungal infections].
    Borges Sa M
    Rev Esp Quimioter; 2008; 21 Spec No 1():14-25. PubMed ID: 18752076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical approach to assess treatment for presumed and documented invasive mold infections in patients with hematologic malignancies: focus on Spanish Society of Chemotherapy Guidelines.
    Kontoyiannis DP
    Rev Esp Quimioter; 2011 Dec; 24(4):173-4. PubMed ID: 22173185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.